BNTX logo

BNTX
BioNTech SE - ADR

18,962
Mkt Cap
$26.51B
Volume
420,563.00
52W High
$124.00
52W Low
$81.20
PE Ratio
-41.92
BNTX Fundamentals
Price
$110.23
Prev Close
$108.80
Open
$109.00
50D MA
$105.18
Beta
0.83
Avg. Volume
1.06M
EPS (Annual)
-$2.99
P/B
1.22
Rev/Employee
$439,432.88
$10,767.80
Loading...
Loading...

About

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
6,772

Frequently Asked Questions

What is Market Cap of BioNTech SE - ADR?
What is the 52-week high for BioNTech SE - ADR?
What is the 52-week low for BioNTech SE - ADR?
What is BioNTech SE - ADR stock price today?
What was BioNTech SE - ADR stock price yesterday?
What is the PE ratio of BioNTech SE - ADR?
What is the Price-to-Book ratio of BioNTech SE - ADR?
What is the 50-day moving average of BioNTech SE - ADR?
How many employees does BioNTech SE - ADR have?

Latest BNTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.